Search results for "Quinolones"

showing 10 items of 103 documents

Supported liquid membrane extraction with single hollow fiber for the analysis of fluoroquinolones from environmental surface water samples

2010

Abstract In this work, the simple analytical method for the determination of four fluoroquinolone antibiotics: ciprofloxacin, enrofloxacin, norfloxacin and danofloxacin, in environmental surface water samples is described. Sample pretreatment step was performed by the application of a technique based on supported liquid membrane extraction with the configuration of single hollow fiber (HF-SLM). The HPLC system with diode array detection was used for final analysis of studied analytes. Various parameters affecting the extraction efficiency during HF-SLM enrichment, such as type of membrane diluent, pH of donor (sample) and acceptor phases, as well as an enrichment time and salt content of sa…

DanofloxacinAnalytical chemistrySodium ChlorideBiochemistryHigh-performance liquid chromatographyDiluentSensitivity and SpecificityAnalytical ChemistryRiversmedicinehollow fiberenvironmental samplesSample preparationfluoroquinolonesChromatography High Pressure LiquidDetection limitChromatographysample preparationChemistryOrganic ChemistryExtraction (chemistry)Reproducibility of ResultsMembranes ArtificialGeneral MedicineHydrogen-Ion ConcentrationAnti-Bacterial Agentssupported liquid membrane extractionWater treatmentHydrochloric AcidEnrichment factorWater Pollutants Chemicalmedicine.drugJournal of Chromatography A
researchProduct

ChemInform Abstract: Microwave-Assisted Synthesis of Polysubstituted 4-Quinolones from Deprotonated α-Aminonitriles.

2011

The α-alkylations of deprotonated Strecker products such as (I) or (V) give a series of intermediates such as (III), (VI), or (X), which undergo microwave-assisted HCN and EtOH eliminations leading to the title quinolones (IV), (VII)/(VIII), or (XI).

DeprotonationChemistry4-quinolonesGeneral MedicineMedicinal chemistryMicrowave assistedChemInform
researchProduct

Therapeutic Monitoring of Aripiprazole by HPLC with Column-Switching and Spectrophotometric Detection

2005

Aripiprazole is a novel atypical antipsychotic drug for the treatment of schizophrenia and schizoaffective disorders (1)(2)(3). The drug is metabolized by the cytochrome P450 isoenzymes 3A4 and 2D6 (4). Because of high interindividual variability in the expression of these enzymes, the aripiprazole concentration varies among healthy individuals after administration of the drug (5). In patients, insufficient response or side effects, such as somnolence, akathisia, or nausea, may result from too low or too high drug concentrations. Therapeutic drug monitoring (TDM), which is established practice for many antipsychotic drugs (6)(7), may be helpful for patients treated with aripiprazole. We mea…

DrugPerphenazinemedicine.drug_classmedia_common.quotation_subjectClinical BiochemistryAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistHigh-performance liquid chromatographyPiperazinesmedicineHumansChromatography High Pressure Liquidmedia_commonmedicine.diagnostic_testChemistryReboxetineBiochemistry (medical)Therapeutic drug monitoringSchizophreniaSpectrophotometry UltravioletAripiprazoleDrug MonitoringAntipsychotic Agentsmedicine.drugClinical Chemistry
researchProduct

Simultaneous determination of different classes of antibiotics in fish and livestock by CE-MS

2007

A specific CE-MS method was developed for the simultaneous determination of 12 antibacterial residues (four sulfonamides: sulfamethazine, sulfathiazole, sulfadiazine, and sulfachlorpyridazine; four beta-lactams: amoxicillin, ampicillin, oxacillin, and penicillin V, and four quinolones: danofloxacin, enrofloxacin, ofloxacin, and flumequine) in fish and livestock. Separation conditions, sheath liquid composition and electrospray parameters were optimized to obtain adequate CE separation and a high sensitivity. CE employed a 75 cm long fused-silica capillary (50 cm thermostated plus 25 cm at room temperature) 75 microm id and a 60 mM ammonium acetate separation buffer at pH 8 with 10% of metha…

ElectrosprayMeatDanofloxacinFish farmingClinical BiochemistryQuinolonesbeta-LactamsBiochemistryAnalytical Chemistrychemistry.chemical_compoundTandem Mass SpectrometrymedicineEnrofloxacinAnimalsSulfonamidesResidue (complex analysis)ChromatographySelected reaction monitoringFishesElectrophoresis CapillaryDrug ResiduesAnti-Bacterial AgentschemistryAnimals DomesticFlumequineAmmonium acetateFood Analysismedicine.drugELECTROPHORESIS
researchProduct

Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin…

2005

Nine coordination compounds of Cu(II) and Co(II) with Ciprofloxacin (HCp) and Enoxacin (HEx) as ligands have been prepared and characterized. Single crystal structural determinations of [Cu(HCp)2(ClO4)2].6H2O (1) and [Co(HEx)2(Ex)]Cl.2CH(3)OH.12H2O (4) are reported. The crystal of 1 is composed of [Cu(HCp)2(ClO4)2] units with the two perchlorate anions semicoordinated, and uncoordinated water molecules. The copper ion, at a crystallographic inversion centre, is in a tetragonally distorted octahedral environment. The structure of 4 consists of cationic monomeric [Co(HEx)2(Ex)]+ units, chloride anions, and uncoordinated methanol and water molecules. The complex is six-coordinate, with a sligh…

EnoxacinStereochemistryCrystal structureQuinolonesCrystallography X-RayGram-Positive BacteriaLigandsBiochemistryCoordination complexInorganic Chemistrychemistry.chemical_compoundPerchlorateAnti-Infective AgentsCiprofloxacinCationsGram-Negative BacteriaOrganometallic CompoundsEnoxacinmedicineMoleculeCiprofloxacin HydrochlorideBond cleavageElectrophoresis Agar Gelchemistry.chemical_classificationMolecular StructureCobaltDNAMonomerchemistryOxidation-ReductionCoppermedicine.drugJournal of Inorganic Biochemistry
researchProduct

VIRULENCE FACTORS AND ANTIMICROBIAL RESISTANCE OF ESCHERICHIA COLI ST131 IN COMMUNITY-ONSET HEALTHCARE-ASSOCIATED INFECTIONS IN SICILY, ITALY

2017

Escherichia coli ST131 is an emerging resistant agent recently called “superbug” in England. This strain is responsible of community-acquired urinary tract infections and nowadays showing increasing resistance to antibiotics like fluoroquinolones and cephalosporins. Survey of virulent bacterial clone is relevant to control its spreading in community. We aim to assess the circulation of resistant clones Escherichia coli ST131 outside of the hospital to prompt control of outbreak in our geographical area. We selected 105 E. coli resistant isolates from community-acquired urinary infections and performed a multiplex PCR to evaluate if they belonged to the ST131 type. We investigated their set …

Escherichia coli urinary tract infections antibiotics fluoroquinolones cephalosporins
researchProduct

LABA/LAMA fixed-dose combinations in patients with COPD: A systematic review

2018

Paola Rogliani,1 Luigino Calzetta,1 Fulvio Braido,2 Mario Cazzola,1 Enrico Clini,3 Girolamo Pelaia,4 Andrea Rossi,5 Nicola Scichilone,6 Fabiano Di Marco7 1Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy; 2Department of Internal Medicine, IRCCS San Martino Genoa University Hospital, Genoa, Italy; 3Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy; 4Department of Medical and Surgical Sciences, Section of Respiratory Diseases, Magna Græcia University, Catanzaro, Italy; 5Pulmonary Unit, University of Verona, Verona, Italy; 6Department of Internal Medicine, University of Palermo, Palermo, Italy; 7…

ExacerbationReviewQuinoloneslaw.inventionPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicineRandomized controlled trialsystematic reviewlaw030212 general & internal medicineCOPDLABA LAMA fixed-dose combination COPD systematic reviewbiologyHealth PolicyOlodaterolLAMAGeneral MedicineLamaRespiratory Function Testsfixed-dose combinationDrug CombinationsTreatment OutcomeIndanssystematic review.hormones hormone substitutes and hormone antagonistsmedicine.drugPulmonary and Respiratory Medicinemedicine.medical_specialtyFixed-dose combinationLABA; LAMA; fixed-dose combination; COPD; systematic reviewLABAMuscarinic AntagonistsSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesInternal medicinemedicineHumansCOPDAdverse effectAdrenergic beta-2 Receptor Agonistslcsh:RC705-779business.industryPublic Health Environmental and Occupational Healthlcsh:Diseases of the respiratory systemCOPD; LABA; LAMA; fixed-dose combination; systematic reviewmedicine.diseasebiology.organism_classificationGlycopyrrolate030228 respiratory systemchemistryDelayed-Action PreparationsIndacaterolbusiness
researchProduct

MALIGNANT EXTERNAL OTITIS. A CASE SERIES FROM AN ITALIAN TERTIARY-CARE HOSPITAL

2014

Objectives: Malignant external otitis (MEO) is an. aggressive and potentially fatal disease that affects the external. auditory canal (EAC) it occurs almost exclusively in elderly, diabetic patients or immune compromised ones. The aim of this study was to describe epidemiological and clinical characteristics of a consecutive series of patients affected by malignant external otitis (MEO) and to conceive a flow-chart for its management. Material and methods: Adult patients diagnosed with and treated for MEO at the University Hospital of Messina, Italy between 2003 and 2013 were identified. Charts were reviewed for history, clinical presentation, laboratory data treatment, and outcomes. Result…

Fluoroquinolones Malignant external otitis
researchProduct

Predominance of the fimH30 Subclone Among Multidrug-Resistant Escherichia coli Strains Belonging to Sequence Type 131 in Italy

2013

GeneticsSettore MED/07 - Microbiologia E Microbiologia ClinicaST131 E. coli fimH30 sub-clone in ItalyBiologymedicine.disease_causeAnti-Bacterial AgentsMicrobiologyMultiple drug resistanceInfectious DiseasesType (biology)Drug Resistance Multiple BacterialCorrespondenceEscherichia colimedicineHumansImmunology and AllergyEscherichia coliEscherichia coli InfectionsFluoroquinolonesSequence (medicine)Journal of Infectious Diseases
researchProduct

Synthesis of 2,3‐Dihydro‐4‐pyridones, 4‐Quinolones, and 2,3‐Dihydro‐4‐azocinones by Visible‐Light Photocatalytic Aerobic Dehydrogenation

2019

Green chemistryChemistryOrganic Chemistry4-quinolonesPhotocatalysisDehydrogenationPhysical and Theoretical ChemistryVisible light photocatalyticPhotochemistryEuropean Journal of Organic Chemistry
researchProduct